Received Jul 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007214 | OT |
No additional AE; HCP called to report TE for PROQUAD with a prior excursion on 6/18/2025 and a current excursion on 07/02/2025 that was administered post excursion to a patient on 07/01/2025. HCP reported that the patient did not experience any adverse side effects f; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 01-Jul-2025, the patient was vaccinated with improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, 0.5 ml, once, lot #Z007214, expiration date: 05-Oct-2026) (route of administration and anatomical location were not reported), for prophylaxis (Product storage error). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) solution for injection (dose, route of administration, expiration date, and lot # were not reported). Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) experienced temperature excursion of 6.8 Fahrenheit (F) degree for 47 minutes, on 18-Jun-2025. The patient did not experience any adverse side effects from administered dose, no additional adverse event. This is one of several reports from the same reporter.
Sterile Diluent